FDA gives Quidel nod on molecular respiratory viral test

03/13/2013 | GenomeWeb Daily News (free registration)

The FDA has given Quidel 510(k) clearance to sell its Molecular RSV + hMPV test, which is used to identify the presence of human metapneumovirus and respiratory syncytial virus as well as differentiate them from each other. The assay already is available for sale in Europe.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA